Jonathan C Fox's Net Worth

-$8.79 Thousand

Estimate Recalculated Nov 1, 2024 02:23PM EST

Who is Jonathan C Fox

Jonathan C Fox does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MyoKardia Inc, Eidos Therapeutics, Inc., and Edgewise Therapeutics, Inc..

SEC CIK

Jonathan C Fox's CIK is 0001655016

Past Insider Trading and Trends

2023 was Jonathan C Fox's most active year for acquiring shares with 3 total transactions. Jonathan C Fox's most active month to acquire stocks was the month of October. 2021 was Jonathan C Fox's most active year for disposing of shares, totalling 2 transactions. Jonathan C Fox's most active month to dispose stocks was the month of December. 2023 saw Jonathan C Fox paying a total of $100,958.16 for 76,711 shares, this is the most they've acquired in one year. In 2021 Jonathan C Fox cashed out on 450,467 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MyoKardia Inc

Chief Medical Officer
Updated May 06, 2016
Form 4
0.76%
1.81K
$8.50
$15.36K
May 06, 2016
241.00K
Grant
Apr 29
Form 4
1.27%
3.00K
$10.00
$30.00K
Nov 05, 2015
239.19K
Purchase
Nov 03
Form 3
Oct 28, 2015
236.19K
Showing 3 results

Eidos Therapeutics, Inc.

See Remarks
Updated Jan 28, 2021
Form 4
-100.00%
-450.97K
Jan 28, 2021
Disposition
Dec 28 - Jan 26
Form 4
-1.50%
-5.77K
$50.16
-$289.26K
Sep 18, 2020
380.97K
Sale
ScheduledSep 17
Form 4
-1.09%
-4.23K
$50.14
-$212.22K
Sep 16, 2020
386.73K
Sale
ScheduledSep 14 - Sep 16
Form 4
-1.27%
-5.00K
$50.00
-$250.00K
Jul 09, 2020
390.97K
Sale
ScheduledJul 07
Form 4
0.28%
1.09K
Jul 01, 2020
395.97K
Acquisition
Jun 29
Form 4
-1.64%
-6.60K
$45.79
-$231.54K
Jun 05, 2020
394.88K
Sale
ScheduledMay 31 - Jun 03
Form 4
-1.24%
-5.00K
$50.00
-$250.00K
Jun 01, 2020
401.48K
Sale
ScheduledMay 28
Form 4
-1.22%
-5.00K
$50.00
-$250.00K
Apr 27, 2020
406.48K
Sale
ScheduledApr 23 - Apr 24
Form 4
-2.39%
-10.00K
$51.57
-$515.71K
Mar 04, 2020
411.48K
Sale
Mar 02
Form 4
-2.70%
-11.63K
$54.00
-$540.00K
Feb 19, 2020
421.48K
Sale
Feb 04 - Feb 13
Form 4
-2.27%
-10.00K
$55.01
-$550.07K
Jan 16, 2020
433.11K
Sale
Jan 14 - Jan 15
Form 4
-0.06%
-270.00
Jan 09, 2020
443.11K
Grant
Dec 26 - Dec 30
Form 4
-2.44%
-11.00K
$58.90
-$589.05K
Dec 05, 2019
443.38K
Sale
Nov 26 - Dec 04
Form 4
-2.17%
-10.00K
$56.52
-$565.22K
Nov 27, 2019
454.38K
Sale
Nov 25
Form 4
-2.12%
-10.00K
$55.11
-$551.07K
Nov 22, 2019
464.38K
Sale
Nov 21
Form 4
-3.08%
-15.00K
$48.65
-$729.70K
Nov 19, 2019
474.38K
Sale
ScheduledNov 15 - Nov 18
Form 4
-1.02%
-5.00K
$36.16
-$180.82K
Oct 16, 2019
489.38K
Sale
ScheduledOct 15
Form 4
-1.01%
-5.00K
$45.74
-$228.72K
Sep 18, 2019
494.38K
Sale
ScheduledSep 16
Form 4
-1.00%
-5.00K
$38.72
-$193.60K
Aug 19, 2019
499.38K
Sale
ScheduledAug 15
Form 4
-2.56%
-13.23K
$26.03
-$579.31K
Jul 17, 2019
504.38K
Sale
May 31 - Jul 15
Form 4
-0.96%
-5.00K
$32.64
-$163.18K
May 31, 2019
516.53K
Sale
May 30
Form 4
-0.95%
-5.00K
$25.03
-$125.15K
May 06, 2019
521.53K
Sale
May 03
Form 4
-0.74%
-3.92K
$18.74
-$114.30K
May 03, 2019
527.61K
Sale
Nov 30 - May 01
Form 4
-0.93%
-5.00K
$23.11
-$115.55K
Apr 16, 2019
531.53K
Sale
Apr 15
Form 4
70.00K
Nov 07, 2018
70.00K
Grant
Nov 05
Form 3
Jun 19, 2018
536.53K
Showing 26 results

Edgewise Therapeutics, Inc.

Investor
Updated Jun 12, 2024
Form 4
20.59K
Jun 12, 2024
20.59K
Grant
Jun 10
Form 4
10.86K
$9.30
$100.96K
Dec 28, 2023
10.86K
Purchase
Dec 26
Form 4
22.12K
Jun 14, 2023
22.12K
Grant
Jun 12
Form 4
43.73K
Mar 07, 2023
43.73K
Grant
Mar 03
Form 3
Mar 07, 2023
Showing 5 results